The Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's Covid-19 vaccine, delaying the roll-out of the country's immunisation programme. Senior officials have been discussing the terms of the deal with the Serum Institute for weeks, hoping to bring down prices below $3 per shot, one of the sources with direct knowledge told Reuters.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/39oC3Mq
via i